4D Molecular Therapeutics Inc - FDMT - stock price prediction, stock price target, analyst ratings from 12 analysts

4D Molecular Therapeutics Inc has a share price target of US$ 28, revenue growth forecast of -85.0%, and profit growth estimate of -106.8% for FY26, based on top 12 analyst calls.